ARCHIVES

Risk of Breast Cancer Recurrence Reduced With Letrozole, International Study Finds

This article is from The Cancer Letter archive.

Vol. 26 No. 10 | October 31, 2003

Download PDF Visit The Full Archive

Related Articles

Group Chairmen Accept Most Changes In Terms Of Award, Object To CTEP Adjustments

December 2, 1988

ASCO Urges Increase In NIH, NCI Budgets.

January 25, 2008

Clinical Trials Approved Last Month By NCI’s CTEP

May 31, 2002

Clinical Trials Approved By NCI CTEP Last Month

May 27, 2011

NCI Programs: HMO Research Network wins $16 Million Grant for Prevention Studies

July 30, 1999

Cancer Patient Lobby Outlines Agenda For FDA Reform, Seeks Role In Discussion

June 23, 1995